Combinostics receives FDA clearance for cNeuro cMRI
The US FDA has issued 510(k) clearance for Combinostic's image quantification software cNeuro cMRI.
The US FDA has issued 510(k) clearance for Combinostic's image quantification software cNeuro cMRI.
Combinostics received a start-up award at the Future X Healthcare event, organized by Roche.
Combinostics is pleased to announce the launch of cDSI, a tool for providing clinical decision support in neurological disorders.
Combinostics was honored with the Digital Health Pioneers award at the Innovators Summit – Digital Health.
Combinostics is pleased to announce the launch of cMRI, a tool for quantitative assessment of MRI brain images. cMRI is a module in cNeuro, Combinostics’ suite of tools for quantitative assessment of brain images.